Programme

Keynote/Plenary and Panel Discussion

Block 1: Brave New World of Healthcare
“LIVE” Opening Ceremony + Keynote + Panel Discussion

Programme on Day 1: 7 October 2021, Thursday
Session 1: 0845 – 1015hrs

Topic 1 : Welcome Address

Speaker :
Prof Philip Choo , Group Chief Executive Officer, National Healthcare Group; Senior Consultant, Department of Geriatric Medicine, Tan Tock Seng Hospital

Topic 2 : Keynote Lecture: Community, Family & Health

Speaker :
Mr Masagos Zulkifli , Minister for Social and Family Development, Second Minister for Health, Minister-in-Charge of Muslim Affairs, Republic of Singapore

Topic 3 : Panel Discussion: Reinventing the Continuum of Healthcare

Moderator :
Ms Salma Khalik , Senior Health Correspondent, The Straits Times
Panellist :
A/Prof Kenneth Mak , Director of Medical Services, Ministry of Health
Prof Philip Choo , Group Chief Executive Officer, National Healthcare Group; Senior Consultant, Department of Geriatric Medicine, Tan Tock Seng Hospital
A/Prof Jeremy Lim , Director, LIGHT, Saw Swee Hock School of Public Health, NUS
Incentivising Health / Preventive Care: Plenary + Panel Discussion (Broadcast Date – 15 Oct 2021)

Topic 1 : Plenary: Health of Our Nation

Speaker :
Adj Prof Derrick Heng , Deputy Director of Medical Services, Public Health Group, Ministry of Health

Topic 2 : Panel Discussion: How To Optimally Incentive Health Promotion And Disease Prevention

Moderator :
Prof Teo Yik Ying , Dean, Saw Swee Hock School of Public Health, National University of Singapore
Panellist :
Adj Prof Derrick Heng , Deputy Director of Medical Services, Public Health Group, Ministry of Health
Dr Alan Ong , Medical Director, AIA Singapore
Dr Joanne Yoong , Senior Economist and Director, University of Southern California; Founder and CEO, Research for Impact Singapore
Mr Zee Yoong Kang , Chief Executive Officer, Health Promotion Board
Block 2: What We Learnt from Covid-19?
“LIVE” What We Learnt from COVID-19? : Plenary + Panel Discussion

Programme on Day 1: 7 October 2021, Thursday
Session 4: 1500 – 1615hrs

Topic 1 : Plenary: What Does The COVID-19 Pandemic Tell Us About Health Systems And Preparedness?

Speaker :
Prof Tan Chorh Chuan , Chief Health Scientist, Ministry of Health Executive Director, MOH Office for Healthcare Transformation

Prior to COVID-19, we had mostly taken a dichotomous approach to 3 sets of key issues namely (1) The SARS vs influenza paradigm of pandemic control; (2) The development of 2 key global priorities in the form of Universal Health Coverage and Epidemic Preparedness; and (3) The building of basic research capabilities vs their rapid translation into real world applications. The COVID-19 pandemic has shown these to be false dichotomies. The presentation argues that we need to develop a new SARS plus Flu paradigm of pandemic prevention and control.  Instead of separate thrusts in UHC, epidemic preparedness and health system development, we must focus on integrated health ecosystems as a critical goal, The pandemic has also shown us new ways by which we can transform the complex process of bringing basic science strengths and discoveries into beneficial real world application.

  • A new SARS plus flu paradigm of pandemic prevention and containment
  • A well integrated health ecosystem is critical
  • Implications for health system transformation

Topic 2 : Panel Discussion: New Models of Partnership in a Post-Covid World

Moderator :
A/Prof David Lye , Director, Infectious Disease Research and Training Office, National Centre for Infectious Diseases; Associate Professor, Lee Kong Chian School of Medicine
Panellist :
Dr Richard Hatchett , Chief Executive Officer, Coalition for Epidemic Preparedness Innovations (CEPI) ,
Prof Leo Yee Sin , Executive Director, Senior Consultant, National Centre for Infectious Diseases
Prof Peter Piot , Professor of Global Health, London School of Hygiene & Tropical Medicine; Distinguished Visiting Professor in Medicine, National University of Singapore
Dr Soumya Swaminathan , Chief Scientist, World Health Organization
Stratifying Health Care
Stratifying Health Care : PLENARY + PANEL DISCUSSION (Broadcast Date – 29 Oct 2021)

Plenary Synopsis

In the past two decades, rapid advances in biomedical science and information technology have put clinical medicine on a cross-road. Our understanding of disease classification and pathophysiological mechanisms is re-written by whole-genome sequencing, epigenetic and meta-genomic analysis.

On the other, expansion of computer memories, speed and analysis, invention of smart phone and internet of things have changed every aspect of our life including healthcare. Genomic data, clinical presentations, diagnostic images and scientific research can be integrated to produce the best patient-centred management protocol.

Before precision medicine can be implemented into daily clinical practice, trust between machine, algorithm, genomics data and patients-physicians-healthcare provider need to be built. Ethical, social and legal issues of data-driven and artificial intelligence guided machine need to be resolved. Cost-effectiveness of Precision Medicine needs to be demonstrated by testing the new diagnostic and treatment modalities can be translated into better outcome at an affordable price. Medical education needs to be reformed and clinical training should include how to work with technology.

  • Technology and development of biomedical sciences have made personalized care of medical condition a reality
  • Proof of improved clinical outcome and cost-effectiveness is yet to be confirmed.
  • Trust on machine learning in making life-and-death decision is still weak and algorithm needs to be tested in different ethnic groups and different jurisdiction.
  • Ethical, social and legal issues of data-driven and artificial intelligence is unclear and, in many areas undefined.

Topic 1 : Plenary: Precision Medicine in 2021: Opportunities and Challenges

Speaker :
Prof Joseph Sung , Dean, Lee Kong Chian School of Medicine Senior Vice President (Health and Life Sciences), Nanyang Technological University

Topic 2 : Panel Discussion: Stratifying Patients for Better Outcomes

Moderator :
Prof Benjamin Seet , Deputy Group Chief Executive Officer (Education and Research), Group Chief Research Officer, National Healthcare Group
Panellist :
Prof John Chambers , Professor of Cardiovascular Epidemiology Chief Investigator for HELIOS and SG100K, Lee Kong Chian School of Medicine, Nanyang Technological University
Dr Lisa Ooi , Vice President, Healthcare & Wellness, Economic Development Board
Prof Joseph Sung , Dean, Lee Kong Chian School of Medicine Senior Vice President (Health and Life Sciences), Nanyang Technological University
Prof Patrick Tan , Executive Director, Genome Institute of Singapore
Innovation in Clinical Care
Innovation in Clinical Care : PLENARY + PANEL DISCUSSION (Broadcast Date – 12 Nov 2021)

Plenary Synopsis

To truly individualise patient treatment, there are a number of considerations to be made. For example, once a treatment regimen is selected, patient responses can be dynamic and evolve over time. In the context of combination therapy, which is a cornerstone of patient care for indications ranging from oncology to chronic disease, drug synergy can be dose-dependent, time-dependent, and patient-specific. In addition to pharmacologic treatment, dynamic patient responses to therapy can be observed for digital cognitive health interventions, also known as digital therapeutics, as well. Importantly, optimising these and other factors can drive substantial inter- and intra-patient variability in treatment outcomes. To address these challenges, the emergence of digital medicine is making it possible to optimise N-of-1 regimen design for patients, and subsequently administer these regimens in a dynamic fashion that evolves alongside the patient. Of note, these strategies can also empower new ways to prospectively acquire patient data, and how this data can be harnessed to modulate intervention, from drug selection to dynamic dosing. Successfully integrating digital medicine-optimised treatment into clinical workflows will ultimately be catalyzed by sustained interdisciplinary engagement between multiple communities spanning clinical, technology, behavioural sciences, healthcare economics, and implementation sciences, and beyond. Towards these objectives, this talk will address our recent clinical development studies for both combination therapy and digital therapy driven by interdisciplinary engagement at WisDM and N.1 to dynamically tailor patient-specific treatment outcomes, reduce healthcare costs, and increase accessibility to practice-changing and optimised medicine.

Topic 1 : Plenary: Harnessing Digital Medicine to Optimise N-of-1 Healthcare

Speaker :
Prof Dean Ho , Provost’s Chair Professor Director, The N.1 Institute for Health (N.1) Director, The Institute for Digital Medicine (WisDM) Head, Department of Biomedical Engineering, Department of Pharmacology, National University of Singapore
  • Technology is changing the way that therapies are developed and administered so that regimens can evolve alongside the patient.
  • Integrating digital medicine-based optimisation into clinical workflows may pinpoint more responders to therapy.
  • Digital medicine is making accessible N-of-1 healthcare a reality.

Topic 2 : Panel Discussion: Harnessing Digital Technology for Clinical Innovation

Moderator :
Adj A/Prof Tan Cher Heng , Assistant Chairman Medical Board (Clinical Research and Innovation), Senior Consultant, Department of Diagnostic Radiology, Tan Tock Seng Hospital
Panellist :
A/Prof Chong Phui-Nah , Chief Executive Officer, National Healthcare Group Polyclinics & Primary Care
Prof Dean Ho , Provost’s Chair Professor Director, The N.1 Institute for Health (N.1) Director, The Institute for Digital Medicine (WisDM) Head, Department of Biomedical Engineering, Department of Pharmacology, National University of Singapore
Dr Lim Jui , Chief Executive Officer, SGInnovate
Prof Louis Phee , Dean, College of Engineering, Tan Chin Tuan Centennial Professor, Nanyang Technological University
Top